Clinical trial · Interventional
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
Pilot Project for Anal Dysplasia Screening in Women With Cervical or Vulvar Dysplasia
NCT01313104CI-TRIAL-00007150withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Lack of funding
Summary
Brief summary (as posted)
This clinical trial studies colposcopy and high resolution anoscopy in screening for anal dysplasia in patients with cervical, vaginal, or vulvar dysplasia or cancer. Screening may help doctors find cancer cells early and plan better treatment for cancer
Conditions
Conditions (25)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Intraepithelial Neoplasia Grade 1 | — | UNRESOLVED | — |
| Cervical Intraepithelial Neoplasia Grade 2 | — | UNRESOLVED | — |
| Cervical Intraepithelial Neoplasia Grade 3 | — | UNRESOLVED | — |
| Recurrent Cervical Cancer | Malignant Cervical Neoplasm | CURATED_BROADER | 0.78 |
| Recurrent Vaginal Cancer | Malignant Vaginal Neoplasm | CURATED_BROADER | 0.78 |
| Recurrent Vulvar Cancer | Malignant Vulvar Neoplasm | CURATED_BROADER | 0.78 |
| Stage 0 Cervical Cancer | Malignant Cervical Neoplasm | CURATED_BROADER | 0.78 |
| Stage 0 Vaginal Cancer | Malignant Vaginal Neoplasm | CURATED_BROADER | 0.78 |
| Stage 0 Vulvar Cancer | Malignant Vulvar Neoplasm | CURATED_BROADER |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cervical Papanicolaou test | Other | — | UNRESOLVED |
| colposcopy | Procedure | — | UNRESOLVED |
| screening method | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Screening
- description
- See Detailed Description
- interventionNames
- Procedure: colposcopy
- Other: cervical Papanicolaou test
- Procedure: screening method
Primary outcomes (2)
- measure
- Risk of anal dysplasia in women with cervical or vulvar dysplasia
- timeFrame
- Over 2 years
- measure
- HPV (Human Papillomavirus) status
- timeFrame
- Over 2 years
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histological confirmation of cervical, vaginal or vulvar intraepithelial neoplasia or cancer are included * Individuals treated with prior radiation therapy and/or chemotherapy are allowed * Women with high-grade dysplasia (carcinoma in situ) are eligible, regardless of their dysplasia free interval * HIV-positive (Human Immunodeficiency Virus) and HIV-negative women will be enrolled; HIV testing will not be performed as part of the study Exclusion Criteria: * Women who are not able to consent are excluded
References
Publications (0)
Data not yet available
No reference posted for this study.